Last reviewed · How we verify
NCT07109479: FORWARD IVL
Safety and Effectiveness of the Single-Use Coronary Forward Intravascular Lithotripsy Catheter Combined With the Intravascular Lithotripsy Therapy Device
NA trial testing Intravascular Lithotripsy in Coronary Arterial Disease in 180 participants. Not yet recruiting.
30 June 2027
Quick facts
| Lead sponsor | Spectrumedics Medical Technology(Shanghai)Co.,Ltd |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 180 |
| Start date | 1 October 2025 |
| Primary completion | 30 June 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Intravascular Lithotripsy
- Rotational Atherectomy
Conditions studied
- Coronary Arterial Disease — all drugs for Coronary Arterial Disease →
Sponsor
Spectrumedics Medical Technology(Shanghai)Co.,Ltd
Who can join
18 and older, any sex, with Coronary Arterial Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The FORWARD IVL trial is a Prospective, Multicenter Study conducted to assess the safety and effectiveness of the Single-Use Coronary Forward Intravascular Lithotripsy Catheter combined with the Intravascular Lithotripsy Therapy Device for the pre-treatment of calcified, stenotic de novo coronary artery lesions .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07109479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intravascular Lithotripsy
Trials testing the same drug.
- NCT06238518 — Intravascular Lithotripsy Versus Conventional Therapy for Severely Calcified Coronary Artery Lesions · NA · unknown
- NCT06089135 — Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Tria · NA · completed
- NCT05858905 — FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter · NA · completed
- NCT05662787 — BOLT Lithotripsy RESTORE ATK Trial · NA · completed
- NCT05535907 — BOLT Lithotripsy RESTORE BTK Trial · NA · completed
Other recruiting trials for Coronary Arterial Disease
Currently open trials in the same condition.
- NCT07293858 — Optical Coherence Tomography: Prognostic Value and Artificial Intelligence · recruiting
Other Spectrumedics Medical Technology(Shanghai)Co.,Ltd trials
Trials by the same sponsor.
- NCT06787547 — Effectiveness and Safety of a Novel Intravascular Lithotripsy System in Severely Calcified Coronary Lesions(COCALP) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07109479 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Spectrumedics Medical Technology(Shanghai)Co.,Ltd
- Last refreshed: 7 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07109479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing